Genetic Analysis AS (XSAT:GEAN)
Sweden flag Sweden · Delayed Price · Currency is SEK · Price in NOK
0.6800
+0.0300 (4.62%)
At close: Aug 6, 2026

Genetic Analysis AS Balance Sheet

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
20.0324.0313.3716.2925.3246.81
Cash & Short-Term Investments
20.0324.0313.3716.2925.3246.81
Cash Growth
87.25%79.70%-17.92%-35.66%-45.90%93.48%
Accounts Receivable
1.161.913.21.92.611.05
Other Receivables
5.16--9.335.757.37
Total Trade Receivables
6.311.913.211.238.368.42
Inventory
1.170.80.761.541.752.37
Other Current Assets
-4.334.37---
Total Current Assets
27.5131.0721.729.0635.4457.6
Net Property, Plant & Equipment
3.673.995.026.198.141.59
Other Intangible Assets
18.0317.4415.7117.8320.8524.31
Long-Term Investments
---0.41--
Other Long-Term Assets
--0.05-0.050.41--
Total Assets
49.2152.4542.3853.4964.4283.49
Accounts Payable
2.022.564.685.594.622.41
Other Current Liabilities
15.9916.417.1710.468.337.55
Total Current Liabilities
18.0218.9711.8416.0512.959.97
Long-Term Debt
6.663.964.4--1.1
Long-Term Leases
2.072.443.645.15-0.33
Other Long-Term Liabilities
---10.97.34-
Total Long-Term Liabilities
8.726.48.0410.97.341.43
Total Liabilities
26.7425.3719.8821.4920.2811.4
Common Stock
41.4541.4529.6322.9214.9514.95
Additional Paid-in Capital
11.8111.817.639.0829.1957.14
Retained Earnings
-30.79-26.18-14.77--0
Shareholders' Equity
22.4727.0822.493244.1472.09
Total Liabilities & Equity
49.2152.4542.3853.4964.4283.49
Total Debt
8.726.48.045.1501.43
Net Cash (Debt)
11.3117.635.3311.1425.3245.38
Net Cash Growth
299.05%230.73%-52.17%-55.99%-44.19%87.56%
Net Cash Per Share
0.170.260.110.291.011.81
Book Value
22.4727.0822.493244.1472.09
Book Value Per Share
0.330.390.460.841.762.88
Tangible Book Value
4.449.646.7914.1723.347.78
Tangible Book Value Per Share
0.070.140.140.370.931.91